Viz.ai Appoints Hypertrophic Cardiomyopathy Medical Advisory Board to Advance Innovation
Press & NewsLeading experts to shape the future of Viz.ai’s HCM strategy and platform SAN FRANCISCO - May 4, 2023 - Viz.ai,...
May 04, 2023
Explore our News & Press
Leading experts to shape the future of Viz.ai’s HCM strategy and platform SAN FRANCISCO - May 4, 2023 - Viz.ai,...
May 04, 2023
Honored for excellence in innovation in AI Assisted Medicine SAN FRANCISCO – April 21, 2023 – Viz.ai, the leader in AI-powered...
Apr 21, 2023
Only company in healthcare to be recognized for the fourth time SAN FRANCISCO – April 12, 2023- Viz.ai, the leader...
Apr 12, 2023
Tailored for trauma care providers to help expedite patient care and improve outcomes SAN FRANCISCO--March 29, 2023 --Viz.ai, the leader...
Mar 29, 2023
New artificial intelligence algorithm flags and triages suspected abdominal aortic aneurysms SAN FRANCISCO – March 21, 2023- Viz.ai, the leader...
Mar 21, 2023
Annual list recognizes innovative medtech companies that are advancing the art and science of healthcare SAN FRANCISCO – March 20,...
Mar 20, 2023
Viz.ai’s AI-powered clinical research platform will be used to find, screen and enroll patients in a landmark study of catheter-directed...
Mar 04, 2023
Viz.ai has submitted a de novo classification request to the FDA for a new AI algorithm intended to identify and...
Mar 02, 2023
Using Viz RECRUIT software, recruitment happens in real-time, around-the-clock, accelerating treatment development for patients with intracerebral hemorrhage SAN FRANCISCO, CA...
Feb 14, 2023
Study, across 166 facilities in 17 states, finds AI-powered care coordination crucial for acute stroke management SAN FRANCISCO - February...
Feb 08, 2023
End-to-end platform for vascular care teams to accelerate the detection and treatment of suspected vascular disease SAN FRANCISCO – January...
Jan 12, 2023
Healthcare technology leader recognized for its culture, diversity, career growth and outlook SAN FRANCISCO - December 15, 2022 - Viz.ai,...
Dec 15, 2022